0001209191-19-029721.txt : 20190514 0001209191-19-029721.hdr.sgml : 20190514 20190514172811 ACCESSION NUMBER: 0001209191-19-029721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190512 FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tucker Sean CENTRAL INDEX KEY: 0001652204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 19824032 MAIL ADDRESS: STREET 1: 385 OYSTER POINT BLVD., SUITE 9A CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxart, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 290 UTAH AVE., SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 550-3500 MAIL ADDRESS: STREET 1: 290 UTAH AVE., SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Aviragen Therapeutics, Inc. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-12 0 0000072444 Vaxart, Inc. VXRT 0001652204 Tucker Sean 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Stock Option (right to buy) 0.77 2019-05-12 4 A 0 124061 0.00 A 2029-05-11 Common Stock 124061 124061 D The option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares subject to the option vesting in equal monthly installments over the next 36 months. /s/ Wouter W. Latour, Attorney-in-Fact for Sean Tucker 2019-05-14